1. Achievable standards, Benchmarks for reporting, and Criteria for evaluating cervical cytopathology (3rd edn) (2013)
https://www.gov.uk/government/publications/cervical-screening-cytopathology-standards-and-evaluation-criteria
(accessed 28 December 2015).
2. 2. Bhatia R, Cubie H, Wennington H, Serrano I, Palmer T, Kavanagh K, Hopkins K, Cuschieri K (2014) Performance of clinically validated HPV tests in a fully vaccinated "catch up" cohort in Scotland. 29th International Papillomavirus Conference
3. 3. Seattle, WA, USA, 21-25 August 2014, CS.OA04.03 p 89. Available at http://ipvsoc.org/sites/default/files/news/HPV-2014-Abstract-eBook.pdf (accessed on 25 August 2015).
4. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine Suppl 10: K1–K16.
5. Cameron RL, Kavanagh K, Pan J, Love J, Cuschieri K, Robertson C, Ahmed S, Palmer TJ, Pollock KGJ (2016) Human papilloma virus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013. Emerg Infect Dis 22: 56–64.